Annual Revenue
$34.16 M
+$14.93 M+77.63%
31 December 2023
Summary:
Foghorn Therapeutics annual revenue is currently $34.16 million, with the most recent change of +$14.93 million (+77.63%) on 31 December 2023. During the last 3 years, it has risen by +$33.73 million (+7843.02%). FHTX annual revenue is now at all-time high.FHTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$7.81 M
+$920.00 K+13.36%
30 September 2024
Summary:
Foghorn Therapeutics quarterly revenue is currently $7.81 million, with the most recent change of +$920.00 thousand (+13.36%) on 30 September 2024. Over the past year, it has dropped by -$9.67 million (-55.33%). FHTX quarterly revenue is now -55.33% below its all-time high of $17.48 million, reached on 30 September 2023.FHTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$25.52 M
-$9.67 M-27.48%
30 September 2024
Summary:
Foghorn Therapeutics TTM revenue is currently $25.52 million, with the most recent change of -$9.67 million (-27.48%) on 30 September 2024. Over the past year, it has dropped by -$7.05 million (-21.66%). FHTX TTM revenue is now -27.48% below its all-time high of $35.19 million, reached on 30 June 2024.FHTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +77.6% | -55.3% | -21.7% |
| 3 y3 years | +7843.0% | +10000.0% | +2877.3% |
| 5 y5 years | - | - | - |
FHTX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +7843.0% | -55.3% | >+9999.0% | -27.5% | +2877.3% |
| 5 y | 5 years | at high | +7843.0% | -55.3% | >+9999.0% | -27.5% | >+9999.0% |
| alltime | all time | at high | +7843.0% | -55.3% | >+9999.0% | -27.5% | >+9999.0% |
Foghorn Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.81 M(+13.4%) | $25.52 M(-27.5%) |
| June 2024 | - | $6.89 M(+36.4%) | $35.19 M(+3.8%) |
| Mar 2024 | - | $5.05 M(-12.5%) | $33.90 M(-0.8%) |
| Dec 2023 | $34.16 M(+77.6%) | $5.77 M(-67.0%) | $34.16 M(+4.9%) |
| Sept 2023 | - | $17.48 M(+212.2%) | $32.57 M(+49.9%) |
| June 2023 | - | $5.60 M(+5.5%) | $21.73 M(+5.4%) |
| Mar 2023 | - | $5.31 M(+26.9%) | $20.62 M(+7.2%) |
| Dec 2022 | $19.23 M | $4.18 M(-36.9%) | $19.23 M(+22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $6.63 M(+47.8%) | $15.76 M(+71.9%) |
| June 2022 | - | $4.49 M(+14.5%) | $9.16 M(+85.0%) |
| Mar 2022 | - | $3.92 M(+449.8%) | $4.95 M(+275.5%) |
| Dec 2021 | $1.32 M(+206.7%) | $713.00 K(+1639.0%) | $1.32 M(+53.9%) |
| Sept 2021 | - | $41.00 K(-85.3%) | $857.00 K(-13.9%) |
| June 2021 | - | $279.00 K(-2.4%) | $995.00 K(+39.0%) |
| Mar 2021 | - | $286.00 K(+13.9%) | $716.00 K(+66.5%) |
| Dec 2020 | $430.00 K | $251.00 K(+40.2%) | $430.00 K(+140.2%) |
| Sept 2020 | - | $179.00 K | $179.00 K |
FAQ
- What is Foghorn Therapeutics annual revenue?
- What is the all time high annual revenue for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual revenue year-on-year change?
- What is Foghorn Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly revenue year-on-year change?
- What is Foghorn Therapeutics TTM revenue?
- What is the all time high TTM revenue for Foghorn Therapeutics?
- What is Foghorn Therapeutics TTM revenue year-on-year change?
What is Foghorn Therapeutics annual revenue?
The current annual revenue of FHTX is $34.16 M
What is the all time high annual revenue for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual revenue is $34.16 M
What is Foghorn Therapeutics annual revenue year-on-year change?
Over the past year, FHTX annual revenue has changed by +$14.93 M (+77.63%)
What is Foghorn Therapeutics quarterly revenue?
The current quarterly revenue of FHTX is $7.81 M
What is the all time high quarterly revenue for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly revenue is $17.48 M
What is Foghorn Therapeutics quarterly revenue year-on-year change?
Over the past year, FHTX quarterly revenue has changed by -$9.67 M (-55.33%)
What is Foghorn Therapeutics TTM revenue?
The current TTM revenue of FHTX is $25.52 M
What is the all time high TTM revenue for Foghorn Therapeutics?
Foghorn Therapeutics all-time high TTM revenue is $35.19 M
What is Foghorn Therapeutics TTM revenue year-on-year change?
Over the past year, FHTX TTM revenue has changed by -$7.05 M (-21.66%)